{"name":"PediaMed Pharmaceuticals","slug":"pediamed-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-29","type":"regulatory","source":"Indian Pharma Post","summary":"Rocket Pharma gets FDA nod for first pediatric gene therapy targeting severe LAD-I - Indian Pharma Post","headline":"Rocket Pharma gets FDA nod for first pediatric gene therapy targeting severe LAD-I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQb3pwVE5RSS1EdU5MNFZzVDN6d3JodDlIV09mYXo5V3NQeWl1em55dWtLY3c0VVhiX00yaGVBVi1IMFNqazhkbVRUclRNamV6LUo2X3J1LUF5dkR6YlBtZmo4cnhXWkhpYktZMEtCempJdV9XUnQ0Y29fZ1hSaVNpazNnY1JhMlBIaWNoSDBmaFRHNlU3YjhrSjVPa1dpVHMxSmxBRWhjbEJqZmltYUl6Y2R3TW9CWlo3alBDMDR6eEpVaUxhb0N3MDMzSnBheHBaSkRvOHpnWW52U1NRRFNWSE5tWmRQTUxYNEhwYURDTWdnS2JuWktyODhKZTdWa2FzdUtXRDBqcnNVX1FpVU5ORnluaERLZw?oc=5","date":"2026-03-27","type":"regulatory","source":"businesswire.com","summary":"Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) - businesswire.com","headline":"Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficie","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPV1ZFc21vMmZtX19DNnQ5S25OM2ZFcjhwRnh0MWE4eFlSbXdLclJPZG5Vcng1X1JLOGN6VFl2ZnlrWFRRTVZTXzJMTVFYS1M3Q3E0alZDa09pc21LVldGdFdpZWdjQy1sY1FpQ3BGMVVBQmFVU2JBcE1BajBNUkFXc1JjSFZVdUlHLS1BOG1WbS1MbGgzMnBraXhfU3dSMEhEZ1pMclpKRUE2ZkV5Y3pGZ1ZoYTNWaGUzOGpTVC1YOVRMVEgtazJfS3Z0SndRV1hLdGwzckFvZ0ZDdFhtNG56TGc2by0tQXoyXzB1QWpR?oc=5","date":"2026-03-16","type":"regulatory","source":"Pharmaceutical Commerce","summary":"Pharma Pulse: FDA Expands Secukinumab Approval for Pediatric HS and Pharmacist-Led Testing Bridges Rural Care Gaps - Pharmaceutical Commerce","headline":"Pharma Pulse: FDA Expands Secukinumab Approval for Pediatric HS and Pharmacist-Led Testing Bridges Rural Care Gaps","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQcDM3X09DbV9za3huamxla2k2RERweWYtVGRINVlpRU9lQWVaVWZGYmZabWhBM2JyMnJqWnFzR3FjTF9ZcEJnQVAxcE05cklUd3ZPQk1aZ3Y2ZU1CSUN2a2FGMGNjN2tmNER6aFJ0RzEtSkozSGszNzZFV1FQNnU4LThVNXlWOTB5UmlJR3NQYXl6ekZHUDVoaXBMcXZPS210d3RlNVVQenhrQVhZODZST18xX2VKcUQxUmZIQVZIN3BYMElka3k1R2FQdkRPNzNpcVB2aG1GZ0tVMEc3OHdvTnRB?oc=5","date":"2026-03-04","type":"regulatory","source":"Pharmaceutical Commerce","summary":"Pharma Pulse: FDA Expands Pediatric Juxtapid Approval and Novo Nordisk Invests €432M in Oral GLP-1 Scaling - Pharmaceutical Commerce","headline":"Pharma Pulse: FDA Expands Pediatric Juxtapid Approval and Novo Nordisk Invests €432M in Oral GLP-1 Scaling","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOR0dOSHZ1aTFLQV9odWRnak42NUVVZ2gtRzNPU29xb2w0bXZaTlNPb0lxajVYLUFnODJpN0w4VnZpR3FORmNMMnkyMFltR3VRMDM3LUd1bUpzUnpYTWtFX3VUUEhqc2EyR1p0WHlYMEJSSlQyZ0JKM1lJamNmWk14Q2ZkSmh6MWk1ZDlR?oc=5","date":"2026-02-04","type":"regulatory","source":"Yahoo Finance","summary":"Pharming Group (ENXTAM:PHARM) Valuation After FDA Complete Response Letter On Joenja Pediatric Filing - Yahoo Finance","headline":"Pharming Group (ENXTAM:PHARM) Valuation After FDA Complete Response Letter On Joenja Pediatric Filing","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-03","type":"regulatory","source":"simplywall.st","summary":"Why Pharming Group (ENXTAM:PHARM) Is Down 16.3% After FDA Rejects Joenja Pediatric Expansion Plan - simplywall.st","headline":"Why Pharming Group (ENXTAM:PHARM) Is Down 16.3% After FDA Rejects Joenja Pediatric Expansion Plan","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQRHRfRkgxdS1RWG9vWU90NVV4NTZLX3VfYk00MUFqUXFHSmVQNUcwWlVQeW90NWYtNURCMG00Y3o4cjVTa25HeDAzU0pLQk82YnZvdjAtWXplSHpIWHkweG1iRlFwSGE5U2ltUUpacXota180WlRNcFhDQlAzeWFOcVBqUlZQbjladEJUYXZSU0s?oc=5","date":"2026-02-02","type":"pipeline","source":"Yahoo Finance","summary":"How Investors May Respond To ARS Pharmaceuticals (SPRY) Expanding EURneffy Pediatric Use Across Europe - Yahoo Finance","headline":"How Investors May Respond To ARS Pharmaceuticals (SPRY) Expanding EURneffy Pediatric Use Across Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOeGg4UFBoWDhoMTl0Q0M0Nl9jcnNYWkFHRzRHTVNkejllU0tvMlI0eVh3WFQ1SG5EdmVjU2M5bWx1d3FCckdDUFptd3dxN0hpTFlpS1Z2MHpBT25nNzhZbjcxdG9COG5OWGxLWGRob2FyUUtBNmpQbXFxaGlBcm9vd21oby1ob0F6N29LZFlkNVA4MzJtbXpjcFE5aF9TdU1wWlpKZUFZT1lnVTZvTEJGVU5nOTdUajd4ajRXTTV2VGVzdzA?oc=5","date":"2026-01-02","type":"trial","source":"Fierce Pharma","summary":"Foresee Pharmaceuticals spots prostate cancer med's potential in rare puberty disease, touts phase 3 win - Fierce Pharma","headline":"Foresee Pharmaceuticals spots prostate cancer med's potential in rare puberty disease, touts phase 3 win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOS2dhTWJzLUhmZGlwTmU4SmxVY2xDTE9RR201T0hHSk0xU3FNWVEyOVNpTldYSWRiV3JyY21PUVFFd1NpZzFFX2ZfZlZWWVRJUS1qbm1YeDNaVHJjUlNUdG5UTlBsXzhPZ2treXY1ZVZlaUNGTkJNWlVPRmR3TjZFeEpBb0U0aXJrT1h5UGszSkQ3WkVYcndWR3BYa3ZvWjJ0cnZyMEpHNA?oc=5","date":"2025-10-09","type":"regulatory","source":"RTTNews","summary":"BioCryst Pharma Nears Defining FDA Moment For Pediatric HAE Therapy - RTTNews","headline":"BioCryst Pharma Nears Defining FDA Moment For Pediatric HAE Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQVmd2TFVpdF9LcEJ2b2ZuLTBjWU5nd1R0OHdvYlFLM0IxTjNiY3dXZVBMcEhCNmxubWk2c2pGS05MUk13NDA0ZTNzWUEwRzJ3Qm9Ic256ZzRnOVV5Zk5oUkUxM284Vk1jQTNScFlRQ1F5R1pJWjN6dzJ5TENDaHdfWU1LU1c5SDRJNTBwWjVaekRWZ2xDcGc?oc=5","date":"2025-08-06","type":"deal","source":"Pharmaceutical Executive","summary":"SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics for $412 Million - Pharmaceutical Executive","headline":"SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics for $412 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWi1sQWtPMjBwbng4ZC1yaDhoTHM3YTRGa1lrUXRrbWdrd0VQNmZTb0kyZFdqNHZScWFOU0pCSmVual9JTHYtbDlyRHMxMWpnd01uVmJuYXhZWGVxUlVqQlZDa21QZ1pKWnhBcTEwTXBSMmdxcHpmOTU0WHJIY2M4WGhtUEtRQUV2aC1QMUFxdDQtTzh0cFIyOUFIdllrbTBYbXVPWGtOTUFNZlNnaW5aZF9KcEtWWWlBS25MM2p1Z1hZZw?oc=5","date":"2025-07-29","type":"pipeline","source":"stjude.org","summary":"Personalized, palatable, precise: Transforming pediatric medication delivery - stjude.org","headline":"Personalized, palatable, precise: Transforming pediatric medication delivery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxNbFlmUmhxdmZJbEs2R09rVG5Wdzhqb3JydUJXNVowNW9yNGN1bG9FckQxNF81QVM3UHdCdTNrN29TNjgwaXFQNW51UW1UcGNScjVud091NUttOUp6VGZQcnU1Q2p0SWNpU096UG90NlA2QXVoQVR0N04wb3U1UnlJVENkQ2FxUXRUZGJ4Wmc2WkhHeG1qaVdfZHhXdXFOSEVXU1lIMlZiX2d4RHY4MGpHRkpJR09NZWZoMVFwY1BvYVBac3gwSXpvU0FwRnlqTTRxUklFYXRKamc5MFh6YW1PUGlHZXV5WC1ZNXA3T2oyZ3g1UlVFckdFVDFuTi01eUlYTUpiTWc0cUcwU1JSQWtV?oc=5","date":"2025-06-18","type":"regulatory","source":"newswire.ca","summary":"Kye Pharmaceuticals Receives Health Canada Approval for New Dosing Guidance for FIRDAPSE ® and an additional Pediatric Indication - newswire.ca","headline":"Kye Pharmaceuticals Receives Health Canada Approval for New Dosing Guidance for FIRDAPSE ® and an additional Pediatric I","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}